Pooled Saliva Specimens for SARS-CoV-2 Testing

Authors:

Abstract
We evaluated saliva (SAL) specimens for SARS-CoV-2 reverse transcriptase PCR (RT-PCR) testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (MT) swabs from 449 individuals with the aim of using saliva for asymptomatic screening. Samples were collected in a drive-through car line for symptomatic individuals ( n = 380) and in the emergency department (ED) ( n = 69).
All Related Versions
Funding Information
  • NIH intramural research funding
  • HHS | NIH | National Cancer Institute

This publication has 25 references indexed in Scilit: